Accelmed Partners II L.P., 10% Owner at NeuroPace Inc (NPCE), bought 588,235 shares at $17.00 ($10.0M) on 2021-04-21, disclosed to the SEC on 2021-04-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.